Phathom Pharmaceuticals (PHAT) Long-Term Debt Issuances: 2023-2024
Historic Long-Term Debt Issuances for Phathom Pharmaceuticals (PHAT) over the last 1 years, with Dec 2024 value amounting to $24.8 million.
- Phathom Pharmaceuticals' Long-Term Debt Issuances fell 37.05% to $24.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $98.7 million, marking a year-over-year change of. This contributed to the annual value of $59.4 million for FY2024, which is 51.08% up from last year.
- Latest data reveals that Phathom Pharmaceuticals reported Long-Term Debt Issuances of $24.8 million as of Q4 2024, which was down 0.00% from $24.8 million recorded in Q2 2024.
- In the past 5 years, Phathom Pharmaceuticals' Long-Term Debt Issuances registered a high of $39.3 million during Q4 2023, and its lowest value of $9.9 million during Q1 2024.
- For the 2-year period, Phathom Pharmaceuticals' Long-Term Debt Issuances averaged around $24.7 million, with its median value being $24.8 million (2024).
- Data for Phathom Pharmaceuticals' Long-Term Debt Issuances shows a maximum YoY crashed of 37.05% (in 2024) over the last 5 years.
- Over the past 2 years, Phathom Pharmaceuticals' Long-Term Debt Issuances (Quarterly) stood at $39.3 million in 2023, then tumbled by 37.05% to $24.8 million in 2024.
- Its Long-Term Debt Issuances was $24.8 million in Q4 2024, compared to $24.8 million in Q2 2024 and $9.9 million in Q1 2024.